Clinical trial Recruiting at 1 site Interventional Ages 16 and up

Labroplasty with the long head of the biceps tendon for recurrent anterior shoulder instability with under 20% glenoid bone loss

Official title: Labroplasty in Cases of Anterior Shoulder Instability With Subcritical Glenoid Bone Loss

Run by Kasr El Aini Hospital · NCT07488039 · Data updated 2026-11-12

This test uses labroplasty with the long head of the biceps tendon to see if it improves shoulder stability, function, and MRI findings in people with recurrent anterior instability and less than 20% glenoid bone loss.

More Recurrent Anterior Shoulder Instability trials

Quick facts

Study typeInterventional
Ages16 Years and up
SexAll
Enrollment21 (estimated)
SponsorKasr El Aini Hospital
Academic / other
Locations1 site (Cairo, Cairo Governorate)
StatusRecruiting
StartedJanuary 1, 2026
Main results expectedDecember 31, 2027
Study endsDecember 31, 2027
Registry record updatedMarch 23, 2026
Trial IDNCT07488039 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults with recurrent anterior shoulder instability, Franceschi type 2–3 labral defects, subcritical glenoid bone loss (<20%), and a positive anterior apprehension test without prior arthroscopic stabilization or biceps tendon pathology.

Probably not a fit

Patients with >20% glenoid bone loss, long head of biceps tendon pathology, multidirectional instability, rotator cuff tears, prior stabilization surgery, shoulder arthritis, proximal humeral fractures, active infection, or who are skeletally immature are unlikely to benefit from this procedure.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This single-center interventional study performs arthroscopic labroplasty using the long head of the biceps tendon in patients who have recurrent anterior shoulder dislocations with subcritical glenoid bone loss (<20%) and thinned or deficient anterior labrum (Franceschi types 2–3). Participants will undergo the arthroscopic procedure at Kasr El Aini Hospital, attend regular postoperative clinic visits, and receive MRI at 6 months to document radiological outcomes. Functional outcome scores and recurrence of instability will be recorded to compare pre- and post-procedure status. The protocol excludes patients with critical glenoid bone loss, long head of biceps pathology, multidirectional instability, prior stabilization surgery, rotator cuff tears, fractures, arthritis, infection, or skeletal immaturity.

Why it matters

Potential benefit: If successful, the procedure could improve shoulder stability and function for patients with subcritical bone loss and potentially avoid more invasive bony reconstruction.

How similar studies have gone: Small case series and biomechanical reports have suggested promise for biceps-based labral augmentation, but there are limited larger or controlled trials, so the approach is relatively novel in clinical study form.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* patients with recurrent anterior shoulder instability with one or more events of anterior shoulder dislocation.
* Franceschi types 2 and 3 labral defects
* subcritical glenoid bone loss \<20%
* positive anterior shoulder apprehension

Exclusion Criteria:

* Critical glenoid bones loss \>20%
* Franceschi type 1 labral defect
* concomitant long head of biceps tendon pathology
* multidirectional instability
* prior arthroscopic shoulder stabilization surgery
* concomitant proximal humeral fractures
* concomitant Rotator cuff tears
* skeletally immature patients
* glenoid pathology
* Shoulder arthritis
* active infection

Where it's running

  • Kasr El Aini Hospital
    Cairo, Cairo Governorate, Egypt
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.